Alyeska Investment Group L.P. Buys 12,198 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Alyeska Investment Group L.P. increased its holdings in UnitedHealth Group by 21.1%, acquiring an additional 12,198 shares, bringing their total ownership to 70,000 shares valued at approximately $36.66 million.
• Multiple analysts have recently revised their price targets for UnitedHealth Group, with a consensus target of $353.00 and ratings ranging from "Buy" to "Underperform."
• UnitedHealth Group also announced a quarterly dividend of $2.21 per share, representing an annualized yield of 2.9% with a payout ratio of 38.30%.

Alyeska Investment Group L.P. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 70,000 shares of the healthcare conglomerate's stock after acquiring an additional 12,198 shares during the period. Alyeska Investment Group L.P.'s holdings in UnitedHealth Group were worth $36,662,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Algert Global LLC lifted its stake in UnitedHealth Group by 5.3% in the fourth quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock valued at $1,606,000 after buying an additional 160 shares during the period. Capital Advantage Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at about $237,000. Finally, CoreCap Advisors LLC lifted its stake in UnitedHealth Group by 127.5% in the fourth quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate's stock valued at $1,797,000 after buying an additional 1,991 shares during the period. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on UNH shares. KeyCorp dropped their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Truist Financial decreased their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Finally, JPMorgan Chase & Co. decreased their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $353.00.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Down 0.5%

UNH stock opened at $307.27 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The business has a 50 day moving average price of $288.51 and a two-hundred day moving average price of $377.17. The company has a market cap of $278.29 billion, a price-to-earnings ratio of 13.31, a P/E/G ratio of 2.00 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.